Tilray Portugal
About Tilray Portugal
Tilray Portugal operates a large EU-GMP certified cannabis cultivation and processing facility in Cantanhede. As part of the Canadian cannabis giant Tilray Brands, the Portuguese operation serves as a key hub for producing medical cannabis for the European market.
Key Facts
- 1Operates one of the largest EU-GMP cannabis facilities in Europe
- 2Parent company Tilray Brands is publicly traded on NASDAQ
- 3Key European production hub supplying medical cannabis to multiple EU countries
Latest News
Tilray's Diversification Strategy Reshapes Cannabis Investment Thesis
TLRY's expansion beyond cannabis into alcohol and wellness creates new valuation framework as traditional sin stock categorization becomes outdated.
Tilray Enters European Cannabis Policy Talks as Regulatory Shift Looms
TLRY participates in EU regulatory discussions as European cannabis markets prepare for potential liberalization across multiple jurisdictions.
Canadian Cannabis Giants Show Mixed Signals Amid Market Consolidation
TLRY, CGC, and VFF navigate regulatory headwinds and operational challenges as the sector searches for sustainable growth paths in 2024.
Frequently Asked Questions
What does Tilray produce in Portugal?
Tilray's Cantanhede facility cultivates and processes medical cannabis products including flower, oils, and extracts, all manufactured under EU-GMP standards for distribution across Europe.
Is Tilray Portugal's parent company publicly traded?
Yes, Tilray Brands (TLRY) is listed on NASDAQ and is one of the largest cannabis companies globally.
More Cannabis Companies in Cantanhede
Cannabis Laws
Products
- Medical Cannabis Flower
- Cannabis Oils
- Cannabis Extracts
- Pharmaceutical Products
Specialties
Company Details
- Location
- Cantanhede, Portugal
- Founded
- 2018
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY